ESAB Stock Analysis: ESAB | NYSE
Metal Fabrication | NYSE, USA | Market Cap: 4.661m USD | 12M Return: -38.8% | US29605J1060 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 58.7M
EPS Trend: 96.5%
Qual. Beats: 0
Rev. Trend: 69.0%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 4.3 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
ESAB Corporation (NYSE: ESAB) is a global manufacturer of consumable products and equipment for cutting, joining, automated welding, and gas control applications. The company was founded in 1904 and is headquartered in North Bethesda, Maryland. It distributes its products through both independent distributors and a direct sales force, operating across Europe, Asia Pacific, South America, and the Middle East. As a constituent of the Industrials sector under the Industrial Machinery & Supplies & Components sub-industry, ESAB serves customers in fabrication, construction, energy, and transportation end markets that rely on welding and cutting technologies.
- Europe industrial slowdown pressures welding equipment demand
- Pricing actions and productivity drive margin expansion
- Reshoring and energy transition boost US fabrication demand
| Net Income: 172.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -2.83 > 1.0 |
| NWC/Revenue: 24.96% < 20% (prev 23.74%; Δ 1.23% < -1%) |
| CFO/TA 0.04 > 3% & CFO 258.9m > Net Income 172.5m |
| Net Debt (2.35b) to EBITDA (443.5m): 5.29 < 3 |
| Current Ratio: 1.96 > 1.5 & < 3 |
| Outstanding Shares: last quarter (61.6m) vs 12m ago 0.44% < -2% |
| Gross Margin: 35.69% > 18% (prev 37.75%; Δ -2.06% > 0.5%) |
| Asset Turnover: 54.61% > 50% (prev 61.77%; Δ -7.16% > 0%) |
| Interest Coverage Ratio: 3.40 > 6 (EBIT TTM 332.6m / Interest Expense TTM 97.7m) |
| A: 0.11 (Total Current Assets 1.53b - Total Current Liabilities 779.0m) / Total Assets 6.56b |
| B: 0.13 (Retained Earnings 865.8m / Total Assets 6.56b) |
| C: 0.06 (EBIT TTM 332.6m / Avg Total Assets 5.50b) |
| D: 0.64 (Book Value of Equity 2.54b / Total Liabilities 3.98b) |
| Altman-Z'' = 2.26 = BBB |
| DSRI: 1.11 (Receivables 554.1m/456.1m, Revenue 3.00b/2.74b) |
| GMI: 1.06 (GM 37.75% / 35.69%) |
| AQI: 1.13 (AQ_t 0.69 / AQ_t-1 0.60) |
| SGI: 1.10 (Revenue 3.00b / 2.74b) |
| TATA: -0.01 (NI 172.5m - CFO 258.9m) / TA 6.56b) |
| Beneish M = -2.74 (Cap -4..+1) = A |
As of September 11, 2026, the stock is trading at USD 69.27 with a total of 1,153,805 shares traded. Over the past week, the price has changed by -6.35%, over one month by -19.06%, over three months by -16.35% and over the past year by -38.78%.
Current recommended Stop Loss: 65.60 (which is 5.3% or 1.2 ATR below the current price).
ESAB has received a consensus analysts rating of 3.91. Therefore, it is recommended to buy ESAB.
- StrongBuy: 5
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 131.2 | 89.4% |
P/E Trailing = 23.5172
P/E Forward = 11.3636
P/S = 1.5535
P/B = 1.9423
P/EG = 0.7237
Revenue TTM = 3.00b USD
EBIT TTM = 332.6m USD
EBITDA TTM = 443.5m USD
Long Term Debt = 2.39b USD (from longTermDebt, last quarter)
Short Term Debt = 32.0m USD (from shortTermDebt, last quarter)
Debt = 2.57b USD (from shortLongTermDebtTotal, last quarter) + Leases 142.2m
Net Debt = 2.35b USD (calculated: Debt 2.57b - CCE 217.5m)
Enterprise Value = 7.01b USD (4.66b + Debt 2.57b - CCE 217.5m)
Interest Coverage Ratio = 3.40 (Ebit TTM 332.6m / Interest Expense TTM 97.7m)
EV/FCF = 35.65x (Enterprise Value 7.01b / FCF TTM 196.6m)
FCF Yield = 2.80% (FCF TTM 196.6m / Enterprise Value 7.01b)
FCF Margin = 6.55% (FCF TTM 196.6m / Revenue TTM 3.00b)
Net Margin = 5.75% (Net Income TTM 172.5m / Revenue TTM 3.00b)
Gross Margin = 35.69% ((Revenue TTM 3.00b - Cost of Revenue TTM 1.93b) / Revenue TTM)
Gross Margin QoQ = 38.04% (prev 36.90%)
Tobins Q-Ratio = 1.07 (Enterprise Value 7.01b / Total Assets 6.56b)
Interest Expense / Debt = 3.81% (Interest Expense 97.7m / Debt 2.57b)
Taxrate = 21.22% (55.2m / 260.1m)
NOPAT = 262.0m (EBIT 332.6m * (1 - 21.22%))
Current Ratio = 1.96 (Total Current Assets 1.53b / Total Current Liabilities 779.0m)
Debt / Equity = 1.01 (Debt 2.57b / totalStockholderEquity, last quarter 2.54b)
Debt / EBITDA = 5.29 (Net Debt 2.35b / EBITDA 443.5m)
Debt / FCF = 11.94 (Net Debt 2.35b / FCF TTM 196.6m)
Total Stockholder Equity = 2.25b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.14% (Net Income 172.5m / Total Assets 6.56b)
RoE = 7.66% (Net Income TTM 172.5m / Total Stockholder Equity 2.25b)
RoCE = 7.16% (EBIT 332.6m / Capital Employed (Equity 2.25b + L.T.Debt 2.39b))
RoIC = 4.62% (NOPAT 262.0m / Invested Capital 5.67b)
WACC = 7.59% (E(4.66b)/V(7.23b) * Re(10.12%) + D(2.57b)/V(7.23b) * Rd(3.81%) * (1-Tc(0.21)))
Discount Rate = 10.12% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 33.89 | Cagr: 0.47%
[DCF] Terminal Value 73.10% ; FCFF base≈221.2m ; Y1≈194.0m ; Y5≈156.7m
[DCF] Fair Price = 2.70 (EV 2.52b - Net Debt 2.35b = Equity 167.8m / Shares 62.1m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 96.50 | EPS CAGR: 7.71% | SUE: -0.73 | # QB: 0
Revenue Correlation: 69.05 | Revenue CAGR: 2.22% | SUE: 1.23 | # QB: 1
EPS current Quarter (2026-09-30): EPS=1.35 | Chg30d=-8.82% | Revisions=-62% | Analysts=9
EPS current Year (2026-12-31): EPS=5.46 | Chg30d=-4.75% | Revisions=-67% | GrowthEPS=+3.5% | GrowthRev=+14.0%
EPS next Year (2027-12-31): EPS=6.53 | Chg30d=-2.25% | Revisions=-22% | GrowthEPS=+19.6% | GrowthRev=+9.6%
[Analyst] Revisions Ratio: -65% (up=2, down=15)